| 000 | 01221 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512131625.0 | ||
| 264 | 0 | _c19680128 | |
| 008 | 196801s 0 0 ger d | ||
| 022 | _a0036-7672 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLabhart, A | |
| 245 | 0 | 0 |
_a[Avoidable and not avoidable damage in hormone therapy. Cortisone osteoporosis and virilizing effect of anabolic steroids]. _h[electronic resource] |
| 260 |
_bSchweizerische medizinische Wochenschrift _cJun 1966 |
||
| 300 |
_a807-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdrenal Hyperplasia, Congenital |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnabolic Agents _xadverse effects |
| 650 | 0 | 4 | _aCalcium Isotopes |
| 650 | 0 | 4 |
_aCortisone _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGluconeogenesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
| 650 | 0 | 4 |
_aPrednisone _xadverse effects |
| 650 | 0 | 4 |
_aProteins _xmetabolism |
| 650 | 0 | 4 |
_aTolbutamide _xadverse effects |
| 650 | 0 | 4 |
_aVirilism _xchemically induced |
| 773 | 0 |
_tSchweizerische medizinische Wochenschrift _gvol. 96 _gno. 25 _gp. 807-13 |
|
| 999 |
_c4866415 _d4866415 |
||